Laure Cayrefourcq
Overview
Explore the profile of Laure Cayrefourcq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smit D, Hoffer K, Bettin B, Kriegs M, Cayrefourcq L, Schumacher U, et al.
Cancer Med
. 2024 Oct;
13(20):e70339.
PMID: 39425449
Background: Research on circulating tumor cells (CTCs) offers the opportunity to better understand the initial steps of blood-borne metastasis as main cause of cancer-related deaths. Here, we have used the...
2.
Kurma K, Eslami-S Z, Alix-Panabieres C, Cayrefourcq L
Cell Adh Migr
. 2024 Sep;
18(1):1-26.
PMID: 39219215
The current constraints associated with cancer diagnosis and molecular profiling, which rely on invasive tissue biopsies or clinical imaging, have spurred the emergence of the liquid biopsy field. Liquid biopsy...
3.
Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project
Bardol T, Dujon A, Taly V, Dunyach-Remy C, Lavigne J, Costa-Silva B, et al.
BMC Cancer
. 2024 Jun;
24(1):709.
PMID: 38853244
Background: Pancreatic cancer, predominantly characterized by ductal adenocarcinoma (PDAC) accounts for 90% of cases and is the fourth leading cause of cancer-related deaths globally. Its incidence is notably increasing. This...
4.
Bao-Caamano A, Costa-Fraga N, Cayrefourcq L, Rodriguez-Casanova A, Muinelo-Romay L, Lopez-Lopez R, et al.
Front Cell Dev Biol
. 2024 Jan;
11:1291179.
PMID: 38188020
Therapy resistance is a major challenge in colorectal cancer management. Epigenetic changes, such as DNA methylation, in tumor cells are involved in the development of acquired resistance during treatment. Here,...
5.
Bardol T, Eslami-S Z, Masmoudi D, Alexandre M, Duboys de Labarre M, Bobrie A, et al.
Cancer Med
. 2023 Dec;
13(1):e6843.
PMID: 38132919
Background: For several years, the AXL tyrosine kinase receptor, a member of the Tyro3-Axl-Mer (TAM) family, has been considered a new strategic target in oncology. AXL overexpression is common in...
6.
Eslami-S Z, Cortes-Hernandez L, Sinoquet L, Gauthier L, Vautrot V, Cayrefourcq L, et al.
Br J Cancer
. 2023 Nov;
130(1):63-72.
PMID: 37973956
Background: Circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), and extracellular vesicles (EVs) are minimally invasive liquid biopsy biomarkers. This study investigated whether they predict prognosis, alone or in combination,...
7.
Bao-Caamano A, Costa-Fraga N, Cayrefourcq L, Jacome M, Rodriguez-Casanova A, Muinelo-Romay L, et al.
Sci Rep
. 2023 Oct;
13(1):16999.
PMID: 37813898
No abstract available.
8.
Bao-Caamano A, Costa-Fraga N, Cayrefourcq L, Jacome M, Rodriguez-Casanova A, Muinelo-Romay L, et al.
Sci Rep
. 2023 Sep;
13(1):15401.
PMID: 37717096
Circulating tumor cells (CTCs) and epigenetic alterations are involved in the development of metastasis from solid tumors, such as colorectal cancer (CRC). The aim of this study was to characterize...
9.
Eslami-S Z, Cortes-Hernandez L, Glogovitis I, Antunes-Ferreira M, DAmbrosi S, Kurma K, et al.
Front Cell Dev Biol
. 2023 Aug;
11:1209846.
PMID: 37601099
Platelets are active players in hemostasis, coagulation and also tumorigenesis. The cross-talk between platelets and circulating tumor cells (CTCs) may have various pro-cancer effects, including promoting tumor growth, epithelial-mesenchymal transition...
10.
Francini S, Duraes M, Rathat G, Macioce V, Mollevi C, Pages L, et al.
Biomolecules
. 2023 Mar;
13(3).
PMID: 36979364
The recurrence of non-metastatic endometrial carcinoma (EC) (6 to 21%) might be due to disseminated tumor cells. This feasibility study investigated whether circulating tumor cells (CTCs) were detectable in blood...